Result: The level of VAS pain in the treatment group decreased from 6.03 ± 0.83 (point) to 2.65 ± 0.85 (point) better than the control group (p<0.05); An improvement of daily living index in the treatment group, ODI score decreased from 16.56 ± 1.78 (point) to 7.29 ± 2.26 (point), better than the control group (p<0.05); Overall treatment results: The treatment group achived results of: Good: 41.2%, fair: 55.9%, average: 2.9%, There was no poor results (p<0.05), no unwanted effects.